The recent shift in Health Economics and Outcomes Research functions across major pharmaceutical companies highlights a lack of understanding of its value.
Denise Garner
Advertisement
Denise Garner, PharmD, MS is a Manager, Value Evidence, AESARA Inc.
Articles by Denise Garner
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
M&A Roundup: LEO Pharma Acquires Dersimelagon, BioMarin Acquires Alesta, OmniAb Enters collaboration with Eli Lilly, Chugai and GSK Enter License Agreement for AID351
2
President Trump Set to Nominate Heidi Overton as FDA Commissioner
3
From Pilot to Profit: How Pharma Leaders Are Scaling AI Across the Drug Lifecycle
4
Pharmaceutical Executive Daily: Unpacking IRA-Driven Formulary Pressure
5